Steady-state and Regenerative Hematopoiesis Occurs Normally in Mice in the Absence of GDF11

Overview

Journal Blood

Publisher Elsevier

Specialty Hematology

Date 2019 Sep 19

PMID 31530563

Citations 5

Authors

Jill M Goldstein

Hilal Sengul

Kathleen A Messemer

Marcos Fernandez-Alfara

Jessica C Garbern

Amy C Kristl

Richard T Lee

Amy J Wagers

Affiliations

Soon will be listed here.

Abstract

Tightly regulated production of mature blood cells is essential for health and survival in vertebrates and dependent on discrete populations of blood-forming (hematopoietic) stem and progenitor cells. Prior studies suggested that inhibition of growth differentiation factor 11 (GDF11) through soluble activin receptor type II (ActRII) ligand traps or neutralizing antibodies promotes erythroid precursor cell maturation and red blood cell formation in contexts of homeostasis and anemia. As Gdf11 is expressed by mature hematopoietic cells, and erythroid precursor cell expression of Gdf11 has been implicated in regulating erythropoiesis, we hypothesized that genetic disruption of Gdf11 in blood cells might perturb normal hematopoiesis or recovery from hematopoietic insult. Contrary to these predictions, we found that deletion of Gdf11 in the hematopoietic lineage in mice does not alter erythropoiesis or erythroid precursor cell frequency under normal conditions or during hematopoietic recovery after irradiation and transplantation. In addition, although hematopoietic cell-derived Gdf11 may contribute to the pool of circulating GDF11 protein during adult homeostasis, loss of Gdf11 specifically in the blood system does not impair hematopoietic stem cell function or induce overt pathological consequences. Taken together, these results reveal that hematopoietic cell-derived Gdf11 is largely dispensable for native and transplant-induced blood formation.

Citing Articles

An emerging class of new therapeutics targeting TGF, Activin, and BMP ligands in pulmonary arterial hypertension.

Upton P, Dunmore B, Li W, Morrell N Dev Dyn. 2022; 252(3):327-342.

PMID: 35434863 PMC: 10952790. DOI: 10.1002/dvdy.478.

The Role of Iron in Benign and Malignant Hematopoiesis.

Sinha S, Pereira-Reis J, Guerra A, Rivella S, Duarte D Antioxid Redox Signal. 2020; 35(6):415-432.

PMID: 33231101 PMC: 8328043. DOI: 10.1089/ars.2020.8155.

Suh J, Lee Y Exp Mol Med. 2020; 52(10):1673-1693.

PMID: 33077875 PMC: 8080601. DOI: 10.1038/s12276-020-00516-4.

Biological basis for efficacy of activin receptor ligand traps in myelodysplastic syndromes.

Verma A, Suragani R, Aluri S, Shah N, Bhagat T, Alexander M J Clin Invest. 2020; 130(2):582-589.

PMID: 31961337 PMC: 6994157. DOI: 10.1172/JCI133678.

Variation in zygotic CRISPR/Cas9 gene editing outcomes generates novel reporter and deletion alleles at the Gdf11 locus.

Goldstein J, Valido A, Lewandowski J, Walker R, Mills M, Messemer K Sci Rep. 2019; 9(1):18613.

PMID: 31819086 PMC: 6901511. DOI: 10.1038/s41598-019-54766-y.

References

Ogilvy S, Metcalf D, Gibson L, Bath M, Harris A, Adams J . Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment. Blood. 1999; 94(6):1855-63. View

Sinha M, Jang Y, Oh J, Khong D, Wu E, Manohar R . Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle. Science. 2014; 344(6184):649-52. PMC: 4104429. DOI: 10.1126/science.1251152. View

Loffredo F, Steinhauser M, Jay S, Gannon J, Pancoast J, Yalamanchi P . Growth differentiation factor 11 is a circulating factor that reverses age-related cardiac hypertrophy. Cell. 2013; 153(4):828-39. PMC: 3677132. DOI: 10.1016/j.cell.2013.04.015. View

Pop R, Shearstone J, Shen Q, Liu Y, Hallstrom K, Koulnis M . A key commitment step in erythropoiesis is synchronized with the cell cycle clock through mutual inhibition between PU.1 and S-phase progression. PLoS Biol. 2010; 8(9). PMC: 2943437. DOI: 10.1371/journal.pbio.1000484. View

Hammers D, Merscham-Banda M, Hsiao J, Engst S, Hartman J, Sweeney H . Supraphysiological levels of GDF11 induce striated muscle atrophy. EMBO Mol Med. 2017; 9(4):531-544. PMC: 5376753. DOI: 10.15252/emmm.201607231. View

Smith S, Zhang X, Zhang X, Gross P, Starosta T, Mohsin S . GDF11 does not rescue aging-related pathological hypertrophy. Circ Res. 2015; 117(11):926-32. PMC: 4636963. DOI: 10.1161/CIRCRESAHA.115.307527. View

McPherron A, Huynh T, Lee S . Redundancy of myostatin and growth/differentiation factor 11 function. BMC Dev Biol. 2009; 9:24. PMC: 2666675. DOI: 10.1186/1471-213X-9-24. View

Dussiot M, Maciel T, Fricot A, Chartier C, Negre O, Veiga J . An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia. Nat Med. 2014; 20(4):398-407. PMC: 7730561. DOI: 10.1038/nm.3468. View

Suragani R, Cadena S, Cawley S, Sako D, Mitchell D, Li R . Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis. Nat Med. 2014; 20(4):408-14. DOI: 10.1038/nm.3512. View

10.

Ma Z, Zhu P, Shi H, Guo L, Zhang Q, Chen Y . PTC-bearing mRNA elicits a genetic compensation response via Upf3a and COMPASS components. Nature. 2019; 568(7751):259-263. DOI: 10.1038/s41586-019-1057-y. View

11.

Egerman M, Cadena S, Gilbert J, Meyer A, Nelson H, Swalley S . GDF11 Increases with Age and Inhibits Skeletal Muscle Regeneration. Cell Metab. 2015; 22(1):164-74. PMC: 4497834. DOI: 10.1016/j.cmet.2015.05.010. View

12.

de Boer J, Williams A, Skavdis G, Harker N, Coles M, Tolaini M . Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol. 2003; 33(2):314-25. DOI: 10.1002/immu.200310005. View

13.

Madisen L, Zwingman T, Sunkin S, Oh S, Zariwala H, Gu H . A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2009; 13(1):133-40. PMC: 2840225. DOI: 10.1038/nn.2467. View

14.

Garbern J, Kristl A, Bassaneze V, Vujic A, Schoemaker H, Sereda R . Analysis of Cre-mediated genetic deletion of in cardiomyocytes of young mice. Am J Physiol Heart Circ Physiol. 2019; 317(1):H201-H212. PMC: 6692736. DOI: 10.1152/ajpheart.00615.2018. View

15.

El-Brolosy M, Kontarakis Z, Rossi A, Kuenne C, Gunther S, Fukuda N . Genetic compensation triggered by mutant mRNA degradation. Nature. 2019; 568(7751):193-197. PMC: 6707827. DOI: 10.1038/s41586-019-1064-z. View

16.

Harper S, Johnson J, Borghetti G, Zhao H, Wang T, Wallner M . GDF11 Decreases Pressure Overload-Induced Hypertrophy, but Can Cause Severe Cachexia and Premature Death. Circ Res. 2018; 123(11):1220-1231. PMC: 6309347. DOI: 10.1161/CIRCRESAHA.118.312955. View

17.

McPherron A, Lawler A, Lee S . Regulation of anterior/posterior patterning of the axial skeleton by growth/differentiation factor 11. Nat Genet. 1999; 22(3):260-4. DOI: 10.1038/10320. View

18.

Guerra A, Oikonomidou P, Sinha S, Zhang J, Lo Presti V, Hamilton C . Lack of does not improve anemia or prevent the activity of RAP-536 in a mouse model of β-thalassemia. Blood. 2019; 134(6):568-572. PMC: 6688431. DOI: 10.1182/blood.2019001057. View

19.

Jones J, Cadena S, Gong C, Wang X, Chen Z, Wang S . Supraphysiologic Administration of GDF11 Induces Cachexia in Part by Upregulating GDF15. Cell Rep. 2018; 22(6):1522-1530. DOI: 10.1016/j.celrep.2018.01.044. View

20.

Poggioli T, Vujic A, Yang P, Macias-Trevino C, Uygur A, Loffredo F . Circulating Growth Differentiation Factor 11/8 Levels Decline With Age. Circ Res. 2015; 118(1):29-37. PMC: 4748736. DOI: 10.1161/CIRCRESAHA.115.307521. View